Table 3.
Anti-HCV activity, anti-HIV activity and cytotoxicity of synthesized compounds in cellular assays.
Compound | Anti-HCV activity: % inhibition 10 μM in Huh7 cells |
Anti-HIV activity (μM) |
Cytotoxicity in CC50 (μM) |
|||
---|---|---|---|---|---|---|
HCV | EC50 | EC90 | PBM | CEM | Vero | |
8a | 80.4 | 70.4 | >100 | >100 | >100 | >100 |
8b | 73.6 | nd | nd | nd | nd | nd |
13 | 76.9 | >100 | >100 | >100 | >100 | >100 |
14 | 60.0 | >100 | >100 | >100 | >100 | >100 |
21 | 73.9 | >100 | >100 | 58.3 | 41.8 | 86.8 |
23 | 85.9 | >100 | >100 | 93.1 | 81.8 | 87.9 |
24 | 53.8 | >100 | >100 | >100 | >100 | >100 |
25 | 83.1 | 35.8 | >100 | 16.0 | 31.6 | 15.6 |
26 | 95.6 | 31.6 | >100 | 35.9 | 55.3 | 41.0 |
27 | 95.0 | 43.9 | >100 | 5.9 | 16.1 | 10.4 |
28 | 60.6 | 55.2 | >100 | 19.6 | 37.6 | 12.7 |
29 | 84.3 | >100 | >100 | 61.9 | 31.6 | 47.0 |
30 | 20.8 | >100 | >100 | >100 | 68.2 | 86.8 |
31 | 78.1 | >100 | >100 | 73.2 | 57.4 | 87.1 |
32 | 0.2 | 62.3 | >100 | 32.9 | 31.6 | 17.1 |
33 | 88.7 | >100 | >100 | 19.8 | 16.8 | 10.3 |
34 | 86.5 | 70.5 | >100 | 62.4 | 52.9 | 80.6 |